Format

Send to

Choose Destination
J Am Acad Dermatol. 2015 Aug;73(2):181-90, quiz 191-2. doi: 10.1016/j.jaad.2015.04.014.

Melanoma in situ: Part I. Epidemiology, screening, and clinical features.

Author information

1
Department of Dermatology, Brown University School of Medicine, Providence, Rhode Island. Electronic address: williamhiggins@brown.edu.
2
Department of Dermatology, Brown University School of Medicine, Providence, Rhode Island.
3
Department of Pathology, Yale University School of Medicine, New Haven, Connecticut.
4
Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut.

Abstract

The incidence of melanoma has steadily increased over the past 3 decades, with melanoma in situ comprising a disproportionately high percentage of the rising incidence. Our understanding of melanoma in situ has been shaped by epidemiologic and clinical studies. Central to a review of melanoma in situ is a focus on its epidemiology, pathology, biologic behavior, treatment, and clinical outcome, which may differ significantly from that of malignant melanoma. Part I of this continuing medical education article reviews the epidemiology, risk factors, and clinical features of melanoma in situ; part II covers the histopathology, treatment options, and clinical management.

KEYWORDS:

lentigo maligna; melanoma; melanoma in situ

PMID:
26183967
DOI:
10.1016/j.jaad.2015.04.014
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center